Proof for prions?

Protein aggregates generated in a test tube were found to infect wild-type hamsters with a disease much like scrapie.

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Protein aggregates generated in a test tube were found to infect wild-type hamsters with a disease much like scrapie. Such a demonstration has, in the past, been called the gold standard of "proof" that infectious protein particles, or prions, free of nucleic acids, are the culprit in transmissible spongiform encephalopathies (TSEs). Study coauthor Claudio Soto says this demonstration,1 together with a paper published by Stanley Prusiner's group last summer,2 should allay most doubts. "There is really little room for skepticism."

Soto's group has been using a process that they call protein misfolding cyclic amplification (PMCA), which aids the conversion of the normal cellular proteins, PrPc, into the protease-resistant aggregates, PrPres, associated with TSE pathology. After seeding PrPc with PrPres, the solution is repeatedly incubated and sonicated to break up growing aggregates.

Crucially, however, the PrPres seed comes from infected hamster brain homogenate, while the normal PrPc comes from healthy hamster ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies